ACTA1 and Hepatic fibrosis: Sirius Red, Masson, and α-SMA staining demonstrated that Cas9/gNLRP3@M-N treatment markedly alleviated CDAHFD-induced hepatic fibrosis (Figure 6K-M, S18).